156 related articles for article (PubMed ID: 34308765)
1. Etomidate ameliorated advanced glycation end-products (AGEs)-induced reduction of extracellular matrix genes expression in chondrocytes.
Sun X; Zhang J; Li Y; Ren W; Wang L
Bioengineered; 2021 Dec; 12(1):4191-4200. PubMed ID: 34308765
[TBL] [Abstract][Full Text] [Related]
2. Linagliptin ameliorated interleukin-29-induced reduction of extracellular matrix genes through the nuclear factor erythroid 2-related factor 2 (Nrf2)/sry-type high-mobility-group box (SOX)-9 axis in an
Li Y; Zhan P; Wang Q; Zhang M; Huang S; Chen D
Bioengineered; 2022 Feb; 13(2):3775-3784. PubMed ID: 35081865
[TBL] [Abstract][Full Text] [Related]
3. Anti-inflammatory capacity of Apremilast in human chondrocytes is dependent on SOX-9.
Zhang Y; Huang X; Yuan Y
Inflamm Res; 2020 Nov; 69(11):1123-1132. PubMed ID: 32809048
[TBL] [Abstract][Full Text] [Related]
4. The protective effects of dulaglutide against advanced glycation end products (AGEs)-induced degradation of type Ⅱ collagen and aggrecan in human SW1353 chondrocytes.
Li H; Chen J; Li B; Fang X
Chem Biol Interact; 2020 May; 322():108968. PubMed ID: 32004530
[TBL] [Abstract][Full Text] [Related]
5. The protective effects of etomidate against interleukin-1β (IL-1β)-induced oxidative stress, extracellular matrix alteration and cellular senescence in chondrocytes.
Yin M; Xu Y
Bioengineered; 2022 Jan; 13(1):985-994. PubMed ID: 34968169
[TBL] [Abstract][Full Text] [Related]
6. Alendronate promotes the gene expression of extracellular matrix mediated by SP-1/SOX-9.
Wang L; Mi B; Zhang Y; Yan H; Zhu H
Hum Exp Toxicol; 2021 Jul; 40(7):1173-1182. PubMed ID: 33522294
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products induce peroxisome proliferator-activated receptor γ down-regulation-related inflammatory signals in human chondrocytes via Toll-like receptor-4 and receptor for advanced glycation end products.
Chen YJ; Sheu ML; Tsai KS; Yang RS; Liu SH
PLoS One; 2013; 8(6):e66611. PubMed ID: 23776688
[TBL] [Abstract][Full Text] [Related]
8. Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes.
Li X; Jia F; Zhu Z; Huang L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1256-1264. PubMed ID: 30942623
[TBL] [Abstract][Full Text] [Related]
9. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract][Full Text] [Related]
10. Cabozantinib prevents AGEs-induced degradation of type 2 collagen and aggrecan in human chondrocytes.
Dong Y; Lin L; Ji Y; Cheng X; Zhang Z
Aging (Albany NY); 2023 Dec; 15(23):13646-13654. PubMed ID: 38059882
[TBL] [Abstract][Full Text] [Related]
11. SOX9 is a regulator of ADAMTSs-induced cartilage degeneration at the early stage of human osteoarthritis.
Zhang Q; Ji Q; Wang X; Kang L; Fu Y; Yin Y; Li Z; Liu Y; Xu X; Wang Y
Osteoarthritis Cartilage; 2015 Dec; 23(12):2259-2268. PubMed ID: 26162802
[TBL] [Abstract][Full Text] [Related]
12. Azilsartan prevented AGE-induced inflammatory response and degradation of aggrecan in human chondrocytes through inhibition of Sox4.
Lei J; He M; Xu L; He C; Li J; Wang W
J Biochem Mol Toxicol; 2021 Aug; 35(8):e22827. PubMed ID: 34051020
[TBL] [Abstract][Full Text] [Related]
13. Linagliptin protects human chondrogenic ATDC5 cells against advanced glycation end products (AGEs)-induced apoptosis via a mitochondria-dependent pathway.
Zhang Y; Huang X; Yuan Y
Chem Biol Interact; 2020 Jan; 315():108901. PubMed ID: 31733186
[TBL] [Abstract][Full Text] [Related]
14. Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis.
Alshenibr W; Tashkandi MM; Alsaqer SF; Alkheriji Y; Wise A; Fulzele S; Mehra P; Goldring MB; Gerstenfeld LC; Bais MV
Arthritis Res Ther; 2017 Aug; 19(1):179. PubMed ID: 28764769
[TBL] [Abstract][Full Text] [Related]
15. The GPR55 antagonist CID16020046 mitigates advanced glycation end products (AGEs)- induced chondrocyte activation.
Zeng Y; Liu Z; Tan X; Lei L
Chem Biol Interact; 2020 Jul; 325():109088. PubMed ID: 32360554
[TBL] [Abstract][Full Text] [Related]
16. Febuxostat mitigates IL-18-induced inflammatory response and reduction of extracellular matrix gene.
Geng Q; Zhang H; Cui Y; Wei Q; Wang S
Am J Transl Res; 2021; 13(3):979-987. PubMed ID: 33841634
[TBL] [Abstract][Full Text] [Related]
17. Matrilin-3 induction of IL-1 receptor antagonist is required for up-regulating collagen II and aggrecan and down-regulating ADAMTS-5 gene expression.
Jayasuriya CT; Goldring MB; Terek R; Chen Q
Arthritis Res Ther; 2012 Sep; 14(5):R197. PubMed ID: 22967398
[TBL] [Abstract][Full Text] [Related]
18. Zafirlukast attenuates advanced glycation end-products (AGEs)-induced degradation of articular extracellular matrix (ECM).
Lei C; Wu S; Wen C; Li Y; Liu N; Huang J; Li L; Fu M; Liu J
Int Immunopharmacol; 2019 Mar; 68():68-73. PubMed ID: 30612086
[TBL] [Abstract][Full Text] [Related]
19. Trelagliptin ameliorates IL-1β-impaired chondrocyte function via the AMPK/SOX-9 pathway.
Liu J; Zuo Q; Li Z; Chen J; Liu F
Mol Immunol; 2021 Dec; 140():70-76. PubMed ID: 34666245
[TBL] [Abstract][Full Text] [Related]
20. CircSERPINE2 weakens IL-1β-caused apoptosis and extracellular matrix degradation of chondrocytes by regulating miR-495/TGFBR2 axis.
Zhang Q; Qiao X; Xia W
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33094798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
